Table of Content

1. Executive Summary
   1.1. Global Autoimmune Disease Testing Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Product Adoption Analysis
   3.2. Technology Assessment
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
   3.5. Key Deals and Mergers
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis
4. Global Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Bn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
       4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2031
   4.3. Global Autoimmune Disease Testing Market Outlook: Product Type
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2023
       4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
           4.3.3.1. Instruments
           4.3.3.2. Reagents & Consumables
   4.4. Market Attractiveness Analysis: Product Type
   4.5. Global Autoimmune Disease Testing Market Outlook: Disease Type
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Bn) Analysis, By Disease Type, 2019 - 2023
       4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
           4.5.3.1. Systemic Lupus Erythematosus
           4.5.3.2. Scleroderma
           4.5.3.3. Vasculitis
           4.5.3.4. Inflammatory Bowel Disease
           4.5.3.5. Rheumatoid Arthritis
           4.5.3.6. Others
   4.6. Market Attractiveness Analysis: Disease Type
   4.7. Global Autoimmune Disease Testing Market Outlook: Test Type
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019 - 2023
       4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
           4.7.3.1. Inflammatory Markers
           4.7.3.2. Routine Laboratory Tests
           4.7.3.3. Anti-Thyroglobulin Antibody
           4.7.3.4. Antibodies and Immunology Test
           4.7.3.5. Others
   4.8. Market Attractiveness Analysis: Test Type
   4.9. Global Autoimmune Disease Testing Market Outlook: End User
       4.9.1. Introduction / Key Findings
       4.9.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
       4.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
           4.9.3.1. Hospitals & Clinics
           4.9.3.2. Diagnostic Laboratories
           4.9.3.3. Research Laboratories
           4.9.3.4. Others
   4.10. Market Attractiveness Analysis: End User
5. Global Autoimmune Disease Testing Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
   5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Autoimmune Disease Testing Market Outlook: Historical (2019 - 2024) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Pricing Analysis
   6.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       6.3.1. By Country
       6.3.2. By Product Type
       6.3.3. By Disease Type
       6.3.4. By Test Type
       6.3.5. By End User
   6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       6.4.1. U.S.
       6.4.2. Canada
   6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
       6.5.1. Instruments
       6.5.2. Reagents & Consumables
   6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
       6.6.1. Systemic Lupus Erythematosus
       6.6.2. Scleroderma
       6.6.3. Vasculitis
       6.6.4. Inflammatory Bowel Disease
       6.6.5. Rheumatoid Arthritis
       6.6.6. Others
   6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
       6.7.1. Inflammatory Markers
       6.7.2. Routine Laboratory Tests
       6.7.3. Anti-Thyroglobulin Antibody
       6.7.4. Antibodies and Immunology Test
       6.7.5. Others
   6.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
       6.8.1. Hospitals & Clinics
       6.8.2. Diagnostic Laboratories
       6.8.3. Research Laboratories
       6.8.4. Others
   6.9. Market Attractiveness Analysis
7. Europe Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       7.2.1. By Country
       7.2.2. By Product Type
       7.2.3. By Disease Type
       7.2.4. By Test Type
       7.2.5. By End User
   7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       7.3.1. U.S.
       7.3.2. Canada
   7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
       7.4.1. Instruments
       7.4.2. Reagents & Consumables
   7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
       7.5.1. Systemic Lupus Erythematosus
       7.5.2. Scleroderma
       7.5.3. Vasculitis
       7.5.4. Inflammatory Bowel Disease
       7.5.5. Rheumatoid Arthritis
       7.5.6. Others
   7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
       7.6.1. Inflammatory Markers
       7.6.2. Routine Laboratory Tests
       7.6.3. Anti-Thyroglobulin Antibody
       7.6.4. Antibodies and Immunology Test
       7.6.5. Others
   7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
       7.7.1. Hospitals & Clinics
       7.7.2. Diagnostic Laboratories
       7.7.3. Research Laboratories
       7.7.4. Others
   7.8. Market Attractiveness Analysis
8. East Asia Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       8.2.1. By Country
       8.2.2. By Product Type
       8.2.3. By Disease Type
       8.2.4. By Test Type
       8.2.5. By End User
   8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
       8.4.1. Instruments
       8.4.2. Reagents & Consumables
   8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
       8.5.1. Systemic Lupus Erythematosus
       8.5.2. Scleroderma
       8.5.3. Vasculitis
       8.5.4. Inflammatory Bowel Disease
       8.5.5. Rheumatoid Arthritis
       8.5.6. Others
   8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
       8.6.1. Inflammatory Markers
       8.6.2. Routine Laboratory Tests
       8.6.3. Anti-Thyroglobulin Antibody
       8.6.4. Antibodies and Immunology Test
       8.6.5. Others
   8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
       8.7.1. Hospitals & Clinics
       8.7.2. Diagnostic Laboratories
       8.7.3. Research Laboratories
       8.7.4. Others
   8.8. Market Attractiveness Analysis
9. South Asia & Oceania Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       9.2.1. By Country
       9.2.2. By Product Type
       9.2.3. By Disease Type
       9.2.4. By Test Type
       9.2.5. By End User
   9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
       9.4.1. Instruments
       9.4.2. Reagents & Consumables
   9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
       9.5.1. Systemic Lupus Erythematosus
       9.5.2. Scleroderma
       9.5.3. Vasculitis
       9.5.4. Inflammatory Bowel Disease
       9.5.5. Rheumatoid Arthritis
       9.5.6. Others
   9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
       9.6.1. Inflammatory Markers
       9.6.2. Routine Laboratory Tests
       9.6.3. Anti-Thyroglobulin Antibody
       9.6.4. Antibodies and Immunology Test
       9.6.5. Others
   9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
       9.7.1. Hospitals & Clinics
       9.7.2. Diagnostic Laboratories
       9.7.3. Research Laboratories
       9.7.4. Others
   9.8. Market Attractiveness Analysis
10. Latin America Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       10.2.1. By Country
       10.2.2. By Product Type
       10.2.3. By Disease Type
       10.2.4. By Test Type
       10.2.5. By End User
   10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
       10.4.1. Instruments
       10.4.2. Reagents & Consumables
   10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
       10.5.1. Systemic Lupus Erythematosus
       10.5.2. Scleroderma
       10.5.3. Vasculitis
       10.5.4. Inflammatory Bowel Disease
       10.5.5. Rheumatoid Arthritis
       10.5.6. Others
   10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
       10.6.1. Inflammatory Markers
       10.6.2. Routine Laboratory Tests
       10.6.3. Anti-Thyroglobulin Antibody
       10.6.4. Antibodies and Immunology Test
       10.6.5. Others
   10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
       10.7.1. Hospitals & Clinics
       10.7.2. Diagnostic Laboratories
       10.7.3. Research Laboratories
       10.7.4. Others
   10.8. Market Attractiveness Analysis
11. Middle East & Africa Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       11.2.1. By Country
       11.2.2. By Product Type
       11.2.3. By Disease Type
       11.2.4. By Test Type
       11.2.5. By End User
   11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
       11.4.1. Instruments
       11.4.2. Reagents & Consumables
   11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
       11.5.1. Systemic Lupus Erythematosus
       11.5.2. Scleroderma
       11.5.3. Vasculitis
       11.5.4. Inflammatory Bowel Disease
       11.5.5. Rheumatoid Arthritis
       11.5.6. Others
   11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
       11.6.1. Inflammatory Markers
       11.6.2. Routine Laboratory Tests
       11.6.3. Anti-Thyroglobulin Antibody
       11.6.4. Antibodies and Immunology Test
       11.6.5. Others
   11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
       11.7.1. Hospitals & Clinics
       11.7.2. Diagnostic Laboratories
       11.7.3. Research Laboratories
       11.7.4. Others
   11.8. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2024
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Abbott Laboratories
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Thermo Fisher Scientific
       12.3.3. F. Hoffmann-La Roche Ltd
       12.3.4. Siemens Healthineers
       12.3.5. Bio-Rad Laboratories
       12.3.6. Beckman Coulter (Danaher Corporation)
       12.3.7. Quest Diagnostics
       12.3.8. PerkinElmer, Inc.
       12.3.9. Hologic, Inc.
       12.3.10. Grifols
       12.3.11. bioMérieux
       12.3.12. Werfen (Inova Diagnostics)
       12.3.13. Ortho Clinical Diagnostics
       12.3.14. Trinity Biotech
       12.3.15. EUROIMMUN (A PerkinElmer Company)
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations